The US Food and Drug Administration (FDA) has announced its plans to address the recommendations put forward in December in a damning report by the Reagan-Udall Foundation on the performance of its Center for Tobacco Products (CTP).
CTP director Brian King said the centre was “committed to addressing all the recommendations outlined in the report as expeditiously as possible”, although the implementation of some of them would require time and external collaboration.
Get access to premium content that is normally only available for subscribers.
For the duration of a week, you can read our news analysis, identify market trends and understand upcoming changes in the industry, which will enable you to get ahead of your competitors.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the ECigIntelligence team.
LATEST ALERTS
